GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fuan Pharmaceutical (Group) Co Ltd (SZSE:300194) » Definitions » Change In Receivables

Fuan Pharmaceutical (Group) Co (SZSE:300194) Change In Receivables : ¥0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Fuan Pharmaceutical (Group) Co Change In Receivables?

Fuan Pharmaceutical (Group) Co's change in receivables for the quarter that ended in Mar. 2025 was ¥0 Mil. It means Fuan Pharmaceutical (Group) Co's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Fuan Pharmaceutical (Group) Co's change in receivables for the fiscal year that ended in Dec. 2024 was ¥47 Mil. It means Fuan Pharmaceutical (Group) Co's Accounts Receivable declined by ¥47 Mil from Dec. 2023 to Dec. 2024 .

Fuan Pharmaceutical (Group) Co's Accounts Receivable for the quarter that ended in Mar. 2025 was ¥205 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Fuan Pharmaceutical (Group) Co's Days Sales Outstanding for the three months ended in Mar. 2025 was 40.06.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Fuan Pharmaceutical (Group) Co's liquidation value for the three months ended in Mar. 2025 was ¥-70 Mil.


Fuan Pharmaceutical (Group) Co Change In Receivables Historical Data

The historical data trend for Fuan Pharmaceutical (Group) Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fuan Pharmaceutical (Group) Co Change In Receivables Chart

Fuan Pharmaceutical (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -75.10 -68.26 -78.50 71.85 46.84

Fuan Pharmaceutical (Group) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Fuan Pharmaceutical (Group) Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fuan Pharmaceutical (Group) Co  (SZSE:300194) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Fuan Pharmaceutical (Group) Co's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=205.31/467.678*91
=40.06

2. In Ben Graham's calculation of liquidation value, Fuan Pharmaceutical (Group) Co's accounts receivable are only considered to be worth 75% of book value:

Fuan Pharmaceutical (Group) Co's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=1008.834-1631.825+0.75 * 205.31+0.5 * 797.859
=-70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fuan Pharmaceutical (Group) Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Fuan Pharmaceutical (Group) Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Fuan Pharmaceutical (Group) Co Business Description

Traded in Other Exchanges
N/A
Address
No.1 Huanan 1 Road, Changshou District, Chongqing, CHN, 401254
Fuan Pharmaceutical (Group) Co Ltd is mainly engaged in the production and sales of bulk drugs and preparations. The company mainly deals with anti-infective, anti-tumor, mental nervous system, cardiovascular and cerebrovascular, digestive system, endocrine and metabolic, bone and muscle systems. Its products include penicillin and cephalosporins.
Executives
Wu Xiong Hui Executives
Huang Tao Directors, executives
Feng Jing Executives
Yu Xue Song Directors, executives
Hong Rong Chuan Executives
Tang Qin Secretary, Director
Wang Tian Xiang Director
Sun Yong Ping Executives
Jiang Chen Directors, executives
Huang Dao Fei Supervisors
Wen Min Director
Zhou Xu Dong Executives
Zhou Zhong Sheng Supervisors

Fuan Pharmaceutical (Group) Co Headlines

No Headlines